AVITA Medical Inc.
8.89
0.07 (0.79%)
At close: Jan 14, 2025, 3:59 PM
8.89
-0.06%
After-hours Jan 14, 2025, 04:00 PM EST
undefined%
Bid 8.89
Market Cap 233.21M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.23
PE Ratio (ttm) -3.99
Forward PE n/a
Analyst Buy
Ask 9.99
Volume 155,855
Avg. Volume (20D) 141,586
Open 9.03
Previous Close 8.82
Day's Range 8.69 - 9.23
52-Week Range 7.51 - 18.93
Beta undefined

About RCEL

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a ...

Sector Healthcare
IPO Date May 14, 2012
Employees 207
Stock Exchange NASDAQ
Ticker Symbol RCEL

Analyst Forecast

According to 5 analyst ratings, the average rating for RCEL stock is "Buy." The 12-month stock price forecast is $17.5, which is an increase of 96.74% from the latest price.

Buy 60.00%
Hold 40.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

AVITA Medical Inc. is scheduled to release its earnings on Feb 13, 2025, after market closes.
Analysts project revenue of $35.85M, reflecting a 152.55% YoY growth and earnings per share of -0.58, making a 107.14% increase YoY.
6 days ago · Source
-36.42%
Avita Medical shares are trading lower after Lake ... Unlock content with Pro Subscription
1 week ago · Source
+3%
Avita Medical shares are trading lower after the company cut its Q4 commercial revenue guidance and delayed expectations for GAAP profitability to Q4 2025